Skip to main content
Clinical Trials/CTRI/2020/12/029965
CTRI/2020/12/029965
Not yet recruiting
未知

Investigating the role of nicotinic neuromodulation in levodopa-induced dyskinesias â?? a multimodal study.

ational Brain Research Centre0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: G20- Parkinsons disease
Sponsor
ational Brain Research Centre
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ational Brain Research Centre

Eligibility Criteria

Inclusion Criteria

  • non\-smoker ( \>10 years)
  • \- able to provide informed consent

Exclusion Criteria

  • The subjects may not be eligible to participate if he/she \-
  • \-Has any neurological disorder (except PD in the patient group)
  • \-Has a current depressive episode, schizophrenia or bipolar disorder (self\-declared and screened with GHQ\-12 (Goldberg et al., 1978; Qin et al., 2018\))
  • \-Has had any head injury with loss of consciousness
  • \- Has had any seizures in the past
  • \-Has cognitive impairment (Mini Mental Status Examination (MMSE) test score \<25\)
  • \-Abuses drugs/alcohol
  • \-Is pregnant or nursing
  • Subjects will not be eligible for MRI scanning if they \-
  • \-Have non\-MRI compatible metal in the body such as a cardiac pacemaker, brain stimulator, surgical metal, cochlear implants, artificial heart valves or dental implants.

Outcomes

Primary Outcomes

Not specified

Similar Trials